Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Guaifenesin measurement |
Has measured component |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin measurement |
Component |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 50 mg/1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 400 mg/10 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 100 mg/5 ml oral væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 675 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 575 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 50 mg + oxtriphyllin 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 50 mg + oxtriphyllin 100 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 90 mg+ theophyllin, vandfri 150 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 600 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
guaifenesin 100 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 1200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin kapsel med modificeret udløsning a 300 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin kapsel med modificeret udløsning a 600 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Guaifenesin poisoning |
Causative agent |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Accidental guaifenesin poisoning |
Causative agent |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Intentional guaifenesin poisoning |
Causative agent |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Forgiftning med guaifenesin, uvist med hvilken hensigt |
Causative agent |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 100 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 100 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
dyphyllin 100 mg + guaifenesin 50 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Diprophylline 200 mg and guaifenesin 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 100 mg + theophyllin 150 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 100 mg + theophyllin 80 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 200 mg + theophyllin 150 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 90 mg + theophyllin 150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 100 mg + theophyllinnatriumglycinat 300 mg eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
dyphyllin 300 mg + guaifenesin 300 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Ephedrine sulfate 25 mg and guaifenesin 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin + oxtriphyllin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing diprophylline and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing dextromethorphan and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
guaifenesin 600 mg med modificeret udløsning/dextromethorphan 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 1200 mg med modificeret udløsning/dextromethorphan 60 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing codeine and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing codeine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
4 |
Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing guaifenesin and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Product containing guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
3 |
Pseudoephedrine + guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Product containing dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
4 |
guaifenesin 1200 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
guaifenesin 600 mg med modificeret udløsning/pseudoephedrin 60 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
|
Accidental guaifenesin poisoning |
Causative agent |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Intentional guaifenesin poisoning |
Causative agent |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Product containing cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing ephedrine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 800 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 1 g oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 675 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 675 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 575 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 575 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
2 |
Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Diprophylline 200 mg and guaifenesin 100 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
2 |
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
2 |
Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Guaifenesin |
Inferred relationship |
Some |
1 |
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Some |
1 |